News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Will Covidien plc (COV) be Restructuring Soon to Reduce Expenses?


8/5/2013 8:40:17 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Covidien reported its fiscal third-quarter earnings Thursday, which mostly met analyst expectations. The Dublin, Ireland, firm saw revenue climb 3% to $2.58 billion in the quarter ended June 28, from $2.51 billion in the same quarter a year ago. Profits fell to $356 million, or 85 cents per diluted share, down from $453 million, or 81 cents per diluted share in the comparable period in 2012.

Help employers find you! Check out all the jobs and post your resume.

Read at News Release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES